Categories: HealthcareNews

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

  • Learn more about Solventum’s long-term strategy to accelerate growth
  • Join in person or via virtual webcast

ST. PAUL, Minn., Feb. 26, 2025 /PRNewswire/ — Solventum (NYSE: SOLV) will host an investor day on Thursday, March 20, 2025, beginning at approximately 1:00 p.m. Eastern Standard Time. The event will be held in New York City and simultaneously webcast online.

More information about this event, including registration information, may be accessed by visiting https://investors.solventum.com. The webcast replay will be available shortly after the live webcast ends.

About Solventum
At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers’ toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients’ lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-to-host-investor-day-on-thursday-march-20-2025-in-new-york-city-302386576.html

SOURCE Solventum

Staff

Recent Posts

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

3 hours ago

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…

3 hours ago